| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 7 |
| 1 | TEMOZOLOMIDE | 7 |
| 2 | BEVACIZUMAB | 6 |
| 3 | DEXAMETHASONE | 6 |
| 4 | DEXAMETHASONE 1.5 MG | 6 |
| 5 | PREDNISOLONE | 5 |
| 6 | PREDNISOLONE ORAL | 5 |
| 7 | PREDNISOLONE ORAL SOLUTION | 5 |
| 8 | LEVETIRACETAM IN SODIUM CHLORIDE | 4 |
| 9 | LEVETIRACETAM INJECTION | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORDAVIPRONE | 1 | 0.0078 |
| 1 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| 2 | ATROPINE SULFATE INJECTION | 2 | 0.0008 |
| 3 | ATROPINE SULFATE MONOHYDRATE | 2 | 0.0008 |
| 4 | PYRIMETHAMINE | 1 | 0.0008 |
| 5 | ZOLBETUXIMAB | 1 | 0.0007 |
| 6 | CERITINIB | 1 | 0.0004 |
| 7 | GLOFITAMAB | 1 | 0.0004 |
| 8 | TEMOZOLOMIDE | 7 | 0.0003 |
| 9 | BRIGATINIB | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Activator [EPC] | 1 | 0.0078 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 3 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Anticholinergic [EPC] | 1 | 0.0001 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 6 | 0.0001 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |